Geode Capital Management’s Longevity Health Holdings, Inc. Common Stock XAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-5,001
Closed -$18.8K 4543
2025
Q1
$18.8K Buy
5,001
+1,763
+54% +$17.1K ﹤0.01% 4359
2024
Q4
$28K Sell
3,238
-34
-1% -$323 ﹤0.01% 4340
2024
Q3
$39.4K Buy
3,272
+501
+18% +$13.7K ﹤0.01% 4307
2024
Q2
$111K Sell
2,771
-226
-8% -$14.9K ﹤0.01% 4112
2024
Q1
$230K Buy
2,997
+25
+0.8% +$2.37K ﹤0.01% 3896
2023
Q4
$331K Buy
2,972
+901
+44% +$77K ﹤0.01% 3760
2023
Q3
$224K Buy
+2,071
New +$312K ﹤0.01% 3938

Other funds holding XAGE

Geode Capital Management's XAGE Position: Q2 2025 in Review

Geode Capital Management sold out of Longevity Health Holdings, Inc. Common Stock (XAGE) in Q2 2025, closing a stake of 5,001 shares — an estimated $18.8K sold.

Geode Capital Management first reported a position in XAGE in Q3 2023 and held it in 7 quarters. The position peaked at $331K in Q4 2023. 11 funds tracked by Wall St. Rank hold XAGE as of Q2 2025.

  • Geode Capital Management reported no remaining Longevity Health Holdings, Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
  • Geode Capital Management sold 5,001 Longevity Health Holdings, Inc. Common Stock shares in Q2 2025, an estimated $18.8K.
  • Geode Capital Management first reported a position in Longevity Health Holdings, Inc. Common Stock in Q3 2023 and held it in 7 quarters.
  • Geode Capital Management's Longevity Health Holdings, Inc. Common Stock position peaked at $331K in Q4 2023.
  • 11 funds tracked by Wall St. Rank held Longevity Health Holdings, Inc. Common Stock as of Q2 2025.

Based on Geode Capital Management's 13F filing for Q2 2025, filed 8 Aug 2025.